AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism CareBusiness Wire • 02/05/26
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to AdvanceBusiness Wire • 02/03/26
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock NowZacks Investment Research • 01/30/26
AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)Zacks Investment Research • 01/12/26
AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased ProfitabilityBusiness Wire • 01/06/26
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallBenzinga • 12/30/25
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026Business Wire • 12/23/25
AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/22/25
AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin ImprovesZacks Investment Research • 10/03/25
AngioDynamics Reports Fiscal Year 2026 First Quarter Financial Results; Med Tech Growth of 26.1% Drives Continued MomentumBusiness Wire • 10/02/25
Top Wall Street Forecasters Revamp AngioDynamics Expectations Ahead Of Q1 EarningsBenzinga • 10/01/25